SCHEMBL440352

SCHEMBL440352

CC1C[C@@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265423 1.00
SCHEMBL8115501 1.00
SCHEMBL1375335 1.00
SCHEMBL1688785 1.00
SCHEMBL5521450 1.00
SCHEMBL30287516 1.00
SCHEMBL4920447 1.00
SCHEMBL438545 1.00
SCHEMBL10441953 0.97 GABRR1 (0.48)
SCHEMBL5500131 0.97 GABRR1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117567266-B Method for preparing 2-methylcyclopropyl carboxylic acid 康龙化成手性医药技术(宁波)有限公司 2024-06-14 CN disclosed
CN-117567266-A Method for preparing 2-methylcyclopropyl carboxylic acid 康龙化成手性医药技术(宁波)有限公司 2024-02-20 CN disclosed
US-20150216861-A1 CYCLOPROPYL AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2015-08-06 US disclosed
US-9029381-B2 Cyclopropyl amide derivatives ASTRAZENECA AB (SE) 2015-05-12 US disclosed
US-8981049-B2 Aziridine mediated native chemical ligation WASHINGTON STATE UNIVERSITY (US) 2015-03-17 US disclosed
US-8486950-B2 Janus kinase inhibitor compounds and methods F. HOFFMANN-LA ROCHE AG (CH) 2013-07-16 US disclosed
US-20130131311-A1 AZIRIDINE MEDIATED NATIVE CHEMICAL LIGATION WASHINGTON STATE UNIVERSITY (US) 2013-05-23 US disclosed
US-20120065193-A1 Cyclopropyl Amide Derivatives '978 ASTRAZENECA AB (SE) 2012-03-15 US disclosed
WO-2009005676-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2009-01-08 WO disclosed
WO-2006043145-A1 INHIBITORS OF HEPATITIS C VIRUS PROTEASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME PFIZER INC. (US) 2006-04-27 WO disclosed